LSE - Delayed Quote GBp
Fusion Antibodies plc (FAB.L)
6.80
-0.68
(-9.09%)
At close: April 25 at 6:32:20 PM GMT+1
Breakdown
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Assets
2,420
2,062
4,915
5,830
Total Liabilities Net Minority Interest
627
939
1,231
1,083
Total Equity Gross Minority Interest
1,793
1,123
3,684
4,747
Total Capitalization
1,793
1,123
3,684
4,747
Common Stock Equity
1,793
1,123
3,684
4,747
Capital Lease Obligations
43
75
69
230
Net Tangible Assets
1,793
1,123
3,684
4,745
Working Capital
1,678
808
3,074
3,709
Invested Capital
1,793
1,123
3,684
4,747
Tangible Book Value
1,793
1,123
3,684
4,745
Total Debt
43
75
69
230
Share Issued
95,365.56
26,014.95
26,014.95
25,610.36
Ordinary Shares Number
95,365.56
26,014.95
26,014.95
25,610.36
3/31/2021 - 12/18/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
2QV0.F Chemomab Therapeutics Ltd.
1.0900
+2.83%
PBN.F Alterity Therapeutics Limited
0.0045
+12.50%
6XY.F HBM Holdings Limited
0.9000
+5.88%
TRMED.OL Thor Medical ASA
2.4000
-2.24%
ELIC.ST Elicera Therapeutics AB (publ)
4.3500
+13.73%
TRX.L Tissue Regenix Group plc
35.00
+0.57%
FARN.L Faron Pharmaceuticals Oy
202.00
-0.25%
BIOVIC-B.ST Biovica International AB (publ)
0.6980
+9.06%
MEDCL.PA MedinCell S.A.
14.97
+0.13%
VVY.AS Vivoryon Therapeutics N.V.
1.7760
-1.88%